Phase III trials of Chinese mRNA Covid vaccine in Nepal cancelled
kathmandupost.com · Mon Feb 21 02:05:43 GMT 2022
Trials of two other Covid vaccines have been running smoothly, according to officials.
Phase III clinical trial of ARCoV , a Chinese mRNA Covid-19 vaccine candidate, will not take place in Nepal, as the vaccine manufacturing company has decided to cancel the study.